Stay updated with breaking news from Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Individuals with hybrid immunity had the highest magnitude and durability of protection, and may be able to extend the period before booster vaccinations are needed compared to individuals who have never been infected, according to a new study. Hybrid immunity refers to immunity developed through a combination of SARS-CoV-2 infection and vaccination.
All estimates of protection waned within months against reinfection but remained high and sustained for hospital admission or severe disease. Individuals with hybrid immunity had the highest magnitude and durability of protection, and as a result might be able to extend the period before booster vaccinations are needed compared to individuals who have never been infected.
The analysis suggests that PIK3CA mutation is associated with worse pathologic complete response and other outcomes. The study was published as a preprint and has not yet been peer reviewed.
The risk for incident type 1 or type 2 diabetes increases after a COVID-19 infection, according to findings from a systematic review and meta-analysis published in Metabolism: Clinical and Experimental. In data from 11 cohorts composed of more than 4.5 million people diagnosed with COVID-19 and more than 42 million controls, the risk for being diagnosed with new-onset diabetes was 64% higher in
In a recent study published in the journal BMC Medicine, researchers estimated the prevalence of new-onset diabetes following coronavirus disease 2019 (COVID-19).